Table 3.
Serum cytokines/chemokines (n = 36).
| Cytokine/chemokines, median [IQR] | Total | Poor | Good |
|---|---|---|---|
| Serum RANTES, pg/mL | 117,300 (59,515–201,368) | 97,290 (38,634–185,167) | 141,428 (67,840–209,952) |
| Serum Fractalkine, pg/mL | 77.2 (4.2–130.6) | 87.4 (0–230) | 67.5 (16.7–116.5) |
| Serum IFN-γ, pg/mL | 6.9 (1.5–17.6) | 7.4 (1.4–12.7) | 4.5 (1.7–25.2) |
| Serum IL-10, pg/mL | 0.07 (0–17.90) | 0 (0–19.5) | 2.71 (0–18.9) |
| Serum IL-4, pg/mL | 0 (0–0) | 0 (0–0) | 0 (0–3.76) |
| Serum IL-6, pg/mL | 2.8 (0–43.3) | 1.1 (0–59.3) | 10.1 (0.9–40.3) |
| Serum MCP-1, pg/mL | 626 (324–852) | 571 (271–872) | 632 (376–850) |
| Serum TNF-α, pg/mL | 37 (19–65) | 35 (18–74) | 37 (19–53) |
| Serum VEGF, pg/mL | 284 (127–564) | 220 (105–865) | 330 (141–547) |
| Serum BLC, pg/mL | 162 (97–256) | 104 (68–227) | 162 (106–294) |
Variables are shown as median (interquartile range).
BLC, B lymphocyte chemokine; IFN, interferon; IFTA, interstitial fibrosis tubular atrophy; IL, interleukin; IQR, interquartile range; MCP, monocyte chemoattractant protein; RANTES, regulated on activation, normal T cell expressed and secreted; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.